# Trial to Assess Chelation Therapy in Critical Limb Ischemia

> **NCT03982693** · PHASE3 · RECRUITING · sponsor: **Mt. Sinai Medical Center, Miami** · enrollment: 50 (estimated)

## Conditions studied

- Critical Limb Ischemia
- Diabetes

## Interventions

- **DRUG:** Edetate Disodium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03982693
- **Lead sponsor:** Mt. Sinai Medical Center, Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-19
- **Primary completion:** 2024-12
- **Final completion:** 2025-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03982693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03982693, "Trial to Assess Chelation Therapy in Critical Limb Ischemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03982693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*